Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

SELL
$1.72 - $2.47 $149,806 - $215,129
-87,097 Reduced 42.42%
118,242 $284,000
Q1 2025

May 15, 2025

BUY
$2.21 - $6.13 $39,780 - $110,340
18,000 Added 9.61%
205,339 $453,000
Q4 2024

Feb 14, 2025

SELL
$4.42 - $8.5 $8,398 - $16,150
-1,900 Reduced 1.0%
187,339 $1.02 Million
Q3 2024

Nov 14, 2024

BUY
$6.84 - $9.73 $1.29 Million - $1.84 Million
189,239 New
189,239 $1.57 Million

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $479M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Clearline Capital LP Portfolio

Follow Clearline Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearline Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Clearline Capital LP with notifications on news.